In a model of diabetic nephropathy in rats induced by STZ-injection, Kuo et al. showed that four weeks of treatment with human recombinant EcSOD improved lifespan and decreased kidney damage [62], demonstrating the protective function of EcSOD against CKD. This evidence concerns the gene SOD3 and diabetic kidney disease.